To dissect the functional contribution of different tumor-derived IFNs to immunoediting and metastasis, we leveraged MACHETE to engineer a refined deletion series that encompass a gradually increasing number of IFN genes (Fig. 8a), resembling deletions seen in cancer patients. The gene discussed is IFNA1; the disease is cancer.